BioCentury | Jan 12, 2021
Finance

Jan. 11 Quick Takes: Megarounds for Valo, Visen; plus NuProbe, Sensei

...led the round with participation from OrbiMed Advisors, Sherpa Healthcare Partners, Cormorant, HBM Healthcare Investments, Pivotal bioVenture Partners China...
BioCentury | Aug 12, 2019
Company News

Aug. 12 Company Quick Takes: Jazz buying Cavion; plus Boehringer, AC Immune, Oncologie

...a tranched $80 million series B in June led by Nan Fung Life Sciences and Pivotal bioVenture Partners China...
BioCentury | Jun 10, 2019
Finance

$80M series B backs Oncologie's biomarkers, which could give new life to old therapies

...Oncologie's strategy of pairing in-licensed, later-stage compounds with biomarkers led Nan Fung Life Sciences and Pivotal bioVenture Partners China...
BioCentury | Jun 8, 2018
Financial News

Oncologie raises $16.5M for dual U.S.-China strategy

...Cancer company Oncologie Ltd. (Cayman Islands) raised $16.5 million in a seed financing led by Pivotal bioVenture Partners China...
BioCentury | Jun 7, 2018
Financial News

Oncologie raises $16.5M for dual U.S.-China strategy

...Cancer company Oncologie Ltd. (Cayman Islands) raised $16.5 million in a seed financing led by Pivotal bioVenture Partners China...
BioCentury | May 25, 2018
Financial News

Pivotal closes China fund at $150M

...stage life sciences companies in the U.S. and Europe (see BioCentury, March 17, 2017) . Pivotal bioVenture Partners China...
BioCentury | May 24, 2018
Financial News

Pivotal closes China fund at $150M

Pivotal bioVenture Partners China closed its USD Fund I at $150 million to invest in Chinese biotechs with in-licensed portfolios. Pivotal China's Jimmy Wei told BioCentury the VC plans to raise another $50 million toward...
Items per page:
1 - 7 of 7
BioCentury | Jan 12, 2021
Finance

Jan. 11 Quick Takes: Megarounds for Valo, Visen; plus NuProbe, Sensei

...led the round with participation from OrbiMed Advisors, Sherpa Healthcare Partners, Cormorant, HBM Healthcare Investments, Pivotal bioVenture Partners China...
BioCentury | Aug 12, 2019
Company News

Aug. 12 Company Quick Takes: Jazz buying Cavion; plus Boehringer, AC Immune, Oncologie

...a tranched $80 million series B in June led by Nan Fung Life Sciences and Pivotal bioVenture Partners China...
BioCentury | Jun 10, 2019
Finance

$80M series B backs Oncologie's biomarkers, which could give new life to old therapies

...Oncologie's strategy of pairing in-licensed, later-stage compounds with biomarkers led Nan Fung Life Sciences and Pivotal bioVenture Partners China...
BioCentury | Jun 8, 2018
Financial News

Oncologie raises $16.5M for dual U.S.-China strategy

...Cancer company Oncologie Ltd. (Cayman Islands) raised $16.5 million in a seed financing led by Pivotal bioVenture Partners China...
BioCentury | Jun 7, 2018
Financial News

Oncologie raises $16.5M for dual U.S.-China strategy

...Cancer company Oncologie Ltd. (Cayman Islands) raised $16.5 million in a seed financing led by Pivotal bioVenture Partners China...
BioCentury | May 25, 2018
Financial News

Pivotal closes China fund at $150M

...stage life sciences companies in the U.S. and Europe (see BioCentury, March 17, 2017) . Pivotal bioVenture Partners China...
BioCentury | May 24, 2018
Financial News

Pivotal closes China fund at $150M

Pivotal bioVenture Partners China closed its USD Fund I at $150 million to invest in Chinese biotechs with in-licensed portfolios. Pivotal China's Jimmy Wei told BioCentury the VC plans to raise another $50 million toward...
Items per page:
1 - 7 of 7